Detection of anti-phosphatidylethanolamine antibodies using flow cytometry

Cytometry

Volumn 36, Issue 1, 1999, Pages 46-51

  Drouvalakis, Katerina Athena ^a,b   Neeson, Paul J ^a   Buchanan, Russell R C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Enzyme linked immunosorbent assay; Flow cytometry; Phosphatidylethanolamine

Indexed keywords

MONOCLONAL ANTIBODY; PHOSPHATIDYLETHANOLAMINE;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; STANDARDIZATION;

ANTIBODIES, ANTIPHOSPHOLIPID; AUTOIMMUNE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MICROSPHERES; PHOSPHATIDYLETHANOLAMINES; POLYSTYRENES;

EID: 0033136522     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990501)36:1<46::AID-CYTO6>3.0.CO;2-3     Document Type: Article

References (37)

1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systematic lupus erythematosus (SLE) and in non-SLE disorders. Ann Int Med 1990;112:682-698.
2. Triplett DA, Brandt JT. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. Hematol Pathol 1988;2:121-143.
3. Exner T, Rickard KA, Kronenberg H. Studies on phospholipid in the action of a lupus coagulation inhibitor. Pathology 1975;7:319-28.
4. Staub HL, Harris EN, Khamashta MA, Savidge G, Chahade WH, Hughes GRV. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis 1989;48:166-169.
5. Rauch J, Tannenbaum M, Tannenbaum H, Cullis PR, Tilcock CPS, Hope MJ, Janoff AS. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 1986;261:9672-9677.
6. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of lupus anticoagulant. J Clin Invest 1980;66:397-405.
7. Kelsey PR, Stevenson KJ, Poller L. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time: the central role of phosphatidylserine. Thromb Haemost 1984;52:72-175.
8. Stevenson KJ, Seddon JM. The role of lipids in the detection of lupus anticoagulant by the dilute Russell Viper venom test: are platelets or reagents containing hexagonal HII phases necessary? Br J Haematol 1994;86:583-589.
9. Drouvalakis KA, Buchanan RRC. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease. J Rheumatol 1998;25:290-295.
10. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rhem Dis 1985;11:591-609.
11. Out HJ, De Groot PG, Van Vliet M, De Gost GC, Nieuwenhuis HK, Derksen RH. Antibodies to platelets in patients with antiphospholipid antibodies. Blood 1991;77:2655-2659.
12. Shattil S, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytomety. Blood 1987;70:307-315.
13. Rote NS, Ng A-K, Dostal-Johnson DA, Nicholson SL, Siekman R. Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin Immunol Immunopathol 1993;66:193-200.
14. Abrams CS, Ellison N, Budzynski A, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-138.
15. Zucker-Franklin D, Karpatkin S. Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. N Engl J Med 1977;297:517-523.
16. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activating platelets and platelet membrane microparticles in normal subjects, and observations in patients during acute repiratory distress syndrome and cariac surgery. J Clin Invest 1986;78:340-348.
17. Fanelli A, Bergamini C, Rapi S, Caldini A, Spinelli A, Buggiani A, Emmi L. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies. Lupus 1997;6:261-267.
18. Childers NK, Michalek SM, Eldridge JH, Denys FR, Berry AK, McGhee JR. Characterisation of liposome suspension by flow cytometry. J Immunol Methods 1989;119:135-143.
19. Pirruccello SJ, Brusnahan SK. Cardiolipin liposomes: A novel flow reagent for detection of anticardiolipin antibodies. J Clin Lab Anal 1990;4:236-240.
20. Stewart MW, Etches WS, Russel AS, Percy JS, Johnston CA, Chew CK, Gordon PA. Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificity. Thromb Haemost 1993;70:603-607.
21. Stewart MW, Gordon PA, Etches WS, Marusy KH, Poppema S, Bigam C, Sykes B. Binding of cardiolipin to polystyrene beads: evidence for a lamellar phase orientation. Br J Haematol 1995;90:900-905.
22. Galli M, Comfurius P, Maassen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Severs EM. Anticardiolipin antibodies (ACA) directed not to cadiolipin but to a plasma cofactor. Lancet 1990;335:1544-1547.
23. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
24. Jones JV, James H, Tan MH, Mansour M. Antiphospholipid antibodies require B2-glycoprotein 1 (Apolipoprotein H) as cofactor. J Rheumatol 1992;19:1397-1402.
25. Obringer AR, Rote N, Walter A. Antiphospholipid antibody binding to bilayer-coated glass microspheres. J Immunol Methods 1995;185:81-93.
26. Laakel M, Bouchard M, Lagacé J. Measurement of mouse antiphospholipid antibodies to solid-phase microspheres by flow cytometry and Alcian blue-pretreated microtire plates in an ELISA. J Immunol Methods 1996;190:267-273.
27. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993;70:787-793.
28. Berard M, Boffa M-C. Influence of the phosphatidylethanolamine (PE) and bovine serum origins on anti-PE antibody detection by ELISA. Thromb Res 1997;85:439-442.
29. Falcon CR, Hoffer AM, Forastiero RR, Carreras LO. Clinical significance of various ELISA assays for detecting antiphospholipid antibodies. Thromb Haemost 1990;64:21-25.
30. Pengo V, Thiagarajan P, Shapiro SS, Heine MJ. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 1987;70:69-76.
31. Branch DW, Rote NS, Dostal DA, Scott JR. Association of lupus anticoagulant with antibody to phosphatidylserine. Clin Immunol Immunopathol 1987;42:63-75.
32. Qamar T, Gharavi AE, Levy RA, Lockshin MD. Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds. J Clin Immunol 1990;10:200-203.
33. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995;86:3083-3089.
34. Drouvalakis KA, Buchanan RRC. Microtitre plate and assay buffer alter detection of anti-phosphatidylethanolamine antibodies in lupus anticoagulant positive plasma. Thromb Res 1999; in press.
35. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody tests. Arch Intern Med 1986;146:2153-2156.
36. Branch WD. Immunologic disease and fetal death. Clin Obstet Gynecol 1987;30:295-311.
37. Cronin ME, Biswas RM, Vanderstracton C, Fleischer TA, Klippel JH. IgG and IgM anticardiolipin antibodies in patients with anticardiolipin associated clinical syndromes. J Rheumatol 1988;15:795-798.